These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30561253)

  • 1. Gender Differences in Patient-Reported Outcomes Among Adults With Atherosclerotic Cardiovascular Disease.
    Okunrintemi V; Valero-Elizondo J; Patrick B; Salami J; Tibuakuu M; Ahmad S; Ogunmoroti O; Mahajan S; Khan SU; Gulati M; Nasir K; Michos ED
    J Am Heart Assoc; 2018 Dec; 7(24):e010498. PubMed ID: 30561253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient-Provider Communication and Health Outcomes Among Individuals With Atherosclerotic Cardiovascular Disease in the United States: Medical Expenditure Panel Survey 2010 to 2013.
    Okunrintemi V; Spatz ES; Di Capua P; Salami JA; Valero-Elizondo J; Warraich H; Virani SS; Blaha MJ; Blankstein R; Butt AA; Borden WB; Dharmarajan K; Ting H; Krumholz HM; Nasir K
    Circ Cardiovasc Qual Outcomes; 2017 Apr; 10(4):. PubMed ID: 28373270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Depression Risk with Patient Experience, Healthcare Expenditure, and Health Resource Utilization Among Adults with Atherosclerotic Cardiovascular Disease.
    Okunrintemi V; Valero-Elizondo J; Michos ED; Salami JA; Ogunmoroti O; Osondu C; Tibuakuu M; Benson EM; Pawlik TM; Blaha MJ; Nasir K
    J Gen Intern Med; 2019 Nov; 34(11):2427-2434. PubMed ID: 31489560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific differences in patient reported outcomes among adults with atherosclerotic cardiovascular disease: Medical expenditure panel survey 2006-2015.
    Okunrintemi V; Benson EA; Derbal O; Miedema MD; Blumenthal RS; Tibuakuu M; Ogunmoroti O; Khan SU; Mamas MA; Gulati M; Michos ED
    Am J Prev Cardiol; 2020 Sep; 3():100083. PubMed ID: 34327463
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in Provision of Medications and Lifestyle Counseling in Ambulatory Settings by Gender and Race for Patients With Atherosclerotic Cardiovascular Disease, 2006-2016.
    Mufarreh A; Shah AJ; Vaccarino V; Kulshreshtha A
    JAMA Netw Open; 2023 Jan; 6(1):e2251156. PubMed ID: 36656581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex-Related Disparities in Cardiovascular Health Care Among Patients With Premature Atherosclerotic Cardiovascular Disease.
    Lee MT; Mahtta D; Ramsey DJ; Liu J; Misra A; Nasir K; Samad Z; Itchhaporia D; Khan SU; Schofield RS; Ballantyne CM; Petersen LA; Virani SS
    JAMA Cardiol; 2021 Jul; 6(7):782-790. PubMed ID: 33881448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin Use in the U.S. for Secondary Prevention of Cardiovascular Disease Remains Suboptimal.
    Ngo-Metzger Q; Zuvekas S; Shafer P; Tracer H; Borsky AE; Bierman AS
    J Am Board Fam Med; 2019; 32(6):807-817. PubMed ID: 31704749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease.
    Mahtta D; Ramsey DJ; Al Rifai M; Nasir K; Samad Z; Aguilar D; Jneid H; Ballantyne CM; Petersen LA; Virani SS
    JAMA Netw Open; 2020 Aug; 3(8):e2011051. PubMed ID: 32816031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sociodemographic Disparities in Influenza Vaccination Among Adults With Atherosclerotic Cardiovascular Disease in the United States.
    Grandhi GR; Mszar R; Vahidy F; Valero-Elizondo J; Blankstein R; Blaha MJ; Virani SS; Andrieni JD; Omer SB; Nasir K
    JAMA Cardiol; 2021 Jan; 6(1):87-91. PubMed ID: 32902562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association Between Intensity of Statin Therapy and Mortality in Patients With Atherosclerotic Cardiovascular Disease.
    Rodriguez F; Maron DJ; Knowles JW; Virani SS; Lin S; Heidenreich PA
    JAMA Cardiol; 2017 Jan; 2(1):47-54. PubMed ID: 27829091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scope and Social Determinants of Food Insecurity Among Adults With Atherosclerotic Cardiovascular Disease in the United States.
    Mahajan S; Grandhi GR; Valero-Elizondo J; Mszar R; Khera R; Acquah I; Yahya T; Virani SS; Blankstein R; Blaha MJ; Cainzos-Achirica M; Nasir K
    J Am Heart Assoc; 2021 Aug; 10(16):e020028. PubMed ID: 34387089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Income Disparities with Patient-Reported Healthcare Experience.
    Okunrintemi V; Khera R; Spatz ES; Salami JA; Valero-Elizondo J; Warraich HJ; Virani SS; Blankstein R; Blaha MJ; Pawlik TM; Dharmarajan K; Krumholz HM; Nasir K
    J Gen Intern Med; 2019 Jun; 34(6):884-892. PubMed ID: 30783877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measures of Financial Hardship From Health Care Expenses Among Families With a Member With Atherosclerotic Cardiovascular Disease in the US.
    Wang SY; Valero-Elizondo J; Cainzos-Achirica M; Desai NR; Nasir K; Khera R
    JAMA Health Forum; 2022 Jul; 3(7):e221962. PubMed ID: 35977226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nondietary Cardiovascular Health Metrics With Patient Experience and Loss of Productivity Among US Adults Without Cardiovascular Disease: The Medical Expenditure Panel Survey 2006 to 2015.
    Tibuakuu M; Okunrintemi V; Savji N; Stone NJ; Virani SS; Blankstein R; Thamman R; Blumenthal RS; Michos ED
    J Am Heart Assoc; 2020 Oct; 9(19):e016744. PubMed ID: 32998625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cumulative Burden of Financial Hardship From Medical Bills Across the Spectrum of Diabetes Mellitus and Atherosclerotic Cardiovascular Disease Among Non-Elderly Adults in the United States.
    Mszar R; Grandhi GR; Valero-Elizondo J; Caraballo C; Khera R; Desai N; Virani SS; Blankstein R; Blaha MJ; Nasir K
    J Am Heart Assoc; 2020 May; 9(10):e015523. PubMed ID: 32394783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimated Impact of US Preventive Services Task Force Recommendations on Use and Cost of Statins for Cardiovascular Disease Prevention.
    Ngo-Metzger Q; Zuvekas SH; Bierman AS
    J Gen Intern Med; 2018 Aug; 33(8):1317-1323. PubMed ID: 29855861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013: Insights From the Medical Expenditure Panel Survey.
    Salami JA; Warraich H; Valero-Elizondo J; Spatz ES; Desai NR; Rana JS; Virani SS; Blankstein R; Khera A; Blaha MJ; Blumenthal RS; Lloyd-Jones D; Nasir K
    JAMA Cardiol; 2017 Jan; 2(1):56-65. PubMed ID: 27842171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender Disparities in Lipid-Lowering Therapy in Cardiovascular Disease: Insights from a Managed Care Population.
    Rodriguez F; Olufade TO; Ramey DR; Friedman HS; Navaratnam P; Heithoff K; Foody JM
    J Womens Health (Larchmt); 2016 Jul; 25(7):697-706. PubMed ID: 26889924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease.
    Pandya A; Sy S; Cho S; Weinstein MC; Gaziano TA
    JAMA; 2015 Jul; 314(2):142-50. PubMed ID: 26172894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing potential population impact of statin treatment for primary prevention of atherosclerotic cardiovascular diseases in the USA: population-based modelling study.
    Yang Q; Zhong Y; Gillespie C; Merritt R; Bowman B; George MG; Flanders WD
    BMJ Open; 2017 Jan; 7(1):e011684. PubMed ID: 28119384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.